<DOC>
	<DOCNO>NCT01924013</DOCNO>
	<brief_summary>The primary aim study : 1 ) determine whether maternal prenatal vitamin D3 supplementation ( 4200 IU/week , 16,800 IU/week , 28,000 IU/week ) versus placebo increase decrease infant length 1 year age , 2 ) determine whether maternal postpartum vitamin D3 supplementation ( 28,000 IU/week ) versus placebo increase decrease length 1 year age among infant born woman receive vitamin D 28,000 U/week pregnancy . Infants enrol study follow 2 year document persistence observe effect measure 1 year age . This study aim enroll 1300 pregnant woman 2nd trimester maternity hospital Dhaka . Participants randomize one three dos vitamin D3 ( 4200 IU/week , 16,800 IU/week , 28,000 IU/week ) placebo throughout pregnancy . Women 28,000 IU/week group additionally randomize either placebo continuation 28,000 IU/week 6 month postpartum . In addition linear length , trial include analysis inflammatory hormonal determinant infant growth , epigenetic phenomenon affect vitamin D metabolism , diarrheal respiratory morbidity infant .</brief_summary>
	<brief_title>Maternal Vitamin D Infant Growth ( MDIG ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Women age 18 year . Gestational age 17 24 complete week estimate base recall last menstrual period ( LMP ) and/or ultrasound . Intends permanently reside trial catchment area least 18 month . History medical condition may predispose participant vitamin D sensitivity , alter vitamin D metabolism and/or hypercalcemia , history renal calculus . Highrisk pregnancy base one follow finding pointofcare test : Severe anemia : hemoglobin &lt; 70 g/L assess Hemocue Moderatesevere proteinuria : ≥ 300 mg/dl ( 3+ 4+ ) base urine dipstick Hypertension : systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg Multiple gestation , major congenital anomaly , severe oligohydramnios base maternal history and/or ultrasound . Unwillingness stop take nonstudy vitamin D calcium supplement multivitamin calcium and/or vitamin D. Currently prescribe vitamin D supplement part physician 's treatment plan vitamin D deficiency . Previous participation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Infant Growth</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Bangladesh</keyword>
</DOC>